Avanza Fonder Ab Cerus Corp Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Cerus Corp stock. As of the latest transaction made, Avanza Fonder Ab holds 109,852 shares of CERS stock, worth $199,930. This represents 0.01% of its overall portfolio holdings.
Number of Shares
109,852Holding current value
$199,930% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CERS
# of Institutions
156Shares Held
147MCall Options Held
84.2KPut Options Held
55.5K-
Baker Bros. Advisors LP New York, NY19.5MShares$35.4 Million0.36% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$33.2 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$19.7 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.54MShares$15.6 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $322M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...